85 GENES FOUND

? »

Limit search: Premium | Premium (Subcell) | Premium (Cell line)

Page of 2 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SPRR3Small proline-rich protein 3Cancer-related genes
Group enriched
CNFNCornifelin
Group enriched
SPINK5Serine peptidase inhibitor, Kazal type 5Disease related genes
Plasma proteins
Predicted secreted proteins
Group enriched
SPRR1ASmall proline-rich protein 1A
Group enriched
RPTNRepetin
Group enriched
RHCGRh family, C glycoproteinPredicted membrane proteins
Transporters
Group enriched
PI3Peptidase inhibitor 3, skin-derivedPlasma proteins
Predicted secreted proteins
Group enriched
LYPD3LY6/PLAUR domain containing 3Predicted membrane proteins
Group enriched
CR2Complement component (3d/Epstein Barr virus) receptor 2CD markers
Disease related genes
Plasma proteins
Predicted membrane proteins
Group enriched
FCER2Fc fragment of IgE, low affinity II, receptor for (CD23)Cancer-related genes
CD markers
Predicted membrane proteins
Group enriched
MS4A1Membrane-spanning 4-domains, subfamily A, member 1CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Group enriched
TRIM29Tripartite motif containing 29
Group enriched
CD19CD19 moleculeCD markers
Disease related genes
Predicted membrane proteins
Group enriched
FCRLAFc receptor-like APredicted membrane proteins
Predicted secreted proteins
Group enriched
TMEM79Transmembrane protein 79Disease related genes
Predicted membrane proteins
Group enriched
CD72CD72 moleculeCD markers
Predicted membrane proteins
Group enriched
CSTBCystatin B (stefin B)Cancer-related genes
Disease related genes
Plasma proteins
Potential drug targets
Transporters
Group enriched
HLA-DOBMajor histocompatibility complex, class II, DO betaPredicted membrane proteins
Predicted secreted proteins
Group enriched
TMEM40Transmembrane protein 40Predicted membrane proteins
Group enriched
TNFRSF13CTumor necrosis factor receptor superfamily, member 13CCD markers
Disease related genes
Predicted membrane proteins
Group enriched
ZNF750Zinc finger protein 750Cancer-related genes
Disease related genes
Group enriched
CXCR5Chemokine (C-X-C motif) receptor 5CD markers
G-protein coupled receptors
Predicted membrane proteins
Group enriched
DSG3Desmoglein 3Plasma proteins
Predicted membrane proteins
Group enriched
SERPINB2Serpin peptidase inhibitor, clade B (ovalbumin), member 2Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Group enriched
SFNStratifinCancer-related genes
Plasma proteins
Group enriched
CCR7Chemokine (C-C motif) receptor 7Cancer-related genes
CD markers
G-protein coupled receptors
Predicted membrane proteins
Group enriched
CLIC3Chloride intracellular channel 3Plasma proteins
Transporters
Group enriched
LTBLymphotoxin beta (TNF superfamily, member 3)Cancer-related genes
Plasma proteins
Group enriched
S100A7S100 calcium binding protein A7Cancer-related genes
Plasma proteins
Group enriched
SELLSelectin LCancer-related genes
Candidate cardiovascular disease genes
CD markers
Plasma proteins
Predicted membrane proteins
Group enriched
ARHGAP25Rho GTPase activating protein 25Plasma proteins
Tissue enhanced
BANK1B-cell scaffold protein with ankyrin repeats 1Disease related genes
Tissue enhanced
BTKBruton agammaglobulinemia tyrosine kinaseDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Tissue enhanced
CCL21Chemokine (C-C motif) ligand 21Cancer-related genes
Plasma proteins
Predicted secreted proteins
Tissue enhanced
CCR6Chemokine (C-C motif) receptor 6CD markers
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
CD180CD180 moleculeCD markers
Predicted membrane proteins
Tissue enhanced
CD22CD22 moleculeCD markers
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CD27CD27 moleculeCancer-related genes
CD markers
Disease related genes
Plasma proteins
Predicted membrane proteins
Tissue enhanced
CD3DCD3d molecule, delta (CD3-TCR complex)CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CD3ECD3e molecule, epsilon (CD3-TCR complex)CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Tissue enhanced
CD3GCD3g molecule, gamma (CD3-TCR complex)CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CD40LGCD40 ligandCancer-related genes
Candidate cardiovascular disease genes
CD markers
Disease related genes
Predicted membrane proteins
Tissue enhanced
CD48CD48 moleculeCD markers
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CD6CD6 moleculeCD markers
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CD79ACD79a molecule, immunoglobulin-associated alphaCancer-related genes
CD markers
Disease related genes
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CD79BCD79b molecule, immunoglobulin-associated betaCancer-related genes
CD markers
Disease related genes
Predicted membrane proteins
Tissue enhanced
CD80CD80 moleculeCD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CDC20Cell division cycle 20Cancer-related genes
Plasma proteins
Tissue enhanced
CH17-132F21.1Uncharacterized protein Predicted secreted proteins
Tissue enhanced
CPNE5Copine VPlasma proteins
Tissue enhanced

Page of 2 | next »